Neucon Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 11 Months
- Open Charges ₹ 1.72 Cr
- Satisfied Charges ₹ 4.63 Cr
About Neucon Pharma
Neucon Pharma Private Limited (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2005 and has a history of 19 years and 11 months. Its registered office is in Goa, Goa, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.72 Cr. The company has closed loans amounting to ₹4.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Asha Prabhu, Amol Arondekar, and Dinesh Prabhu serve as directors at the Company.
Company Details
-
Location
Goa, Goa, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100GA2005PTC003873
-
Company No.
003873
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Feb 2005
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Neucon Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Asha Prabhu
|
Director | 23-Feb-2007 | Current |
|
Amol Arondekar
|
Director | 28-Feb-2005 | Current |
|
Dinesh Prabhu
|
Additional Director | 03-Apr-2008 | Current |
Financial Performance of Neucon Pharma.
Enhance accessibility to Neucon Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neucon Pharma?
Unlock access to Neucon Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹17.20 M
₹46.30 M
Charges Breakdown by Lending Institutions
- The Madgaum Urban Co-Operative Bank Limited : 1.07 Cr
- The Madgaum Urban Co.Op. Bank Limited : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Sep 2009 | The Madgaum Urban Co-Operative Bank Limited | ₹1.07 Cr | Open |
| 04 Sep 2009 | The Madgaum Urban Co.Op. Bank Limited | ₹6.50 M | Open |
| 16 Sep 2008 | Bank Of Maharastra | ₹1.77 Cr | Satisfied |
| 12 Aug 2008 | Bank Of Maharashtra | ₹1.77 Cr | Satisfied |
| 13 Apr 2006 | State Bank Of India | ₹1.09 Cr | Satisfied |
How Many Employees Work at Neucon Pharma?
Neucon Pharma has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neucon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neucon Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
